What is the Buying Price of Onesource Specialty Pharma Share?

The Buying Price of Onesource Specialty Pharma share is 1834.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Onesource Specialty Pharma Share at Choice?

To buy Onesource Specialty Pharma stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Onesource Specialty Pharma, choose your preferred order type, and place the trade.

What is the PE ratio of Onesource Specialty Pharma Shares?

The Price-to-earnings (P/E) ratio of Onesource Specialty Pharma shares is 0. You can compare it with the sector average for relative valuation.

What is the PB ratio of Onesource Specialty Pharma Shares?

The Price to Book (P/B) ratio Onesource Specialty Pharma shares is 3.61. Useful to assess the stock's value relative to its book value.

Is Onesource Specialty Pharma Overvalued?

To assess Onesource Specialty Pharma’s valuation compare Sector P/E, P/B which are 71.32 & 3.47 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Onesource Specialty Pharma?

The Market Cap of Onesource Specialty Pharma is 21030.70 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Onesource Specialty Pharma Share Price?

The 52 week high and low prices of Onesource Specialty Pharma share price is 2248 & 1057. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Onesource Specialty Pharma belong to?

Onesource Specialty Pharma belongs to the Healthcare sector.

Onesource Specialty Pharma Share price

ONESOURCE

Healthcare Large Cap

1834.8

14.90 (0.82%)

NSE

BSE

Last updated on 15 May, 2026 | 15:59 IST

BUYSELL

Today's High

1860.00

Today's Low

1777.00

52 Week Low

1057.00

52 Week High

2248.00

Free Demat with Zero AMC*

Onesource Specialty Pharma Chart

ChartIQ

TradingView

Onesource Specialty Pharma Share Key Metrics

Volume

2.56 L

Market Cap

21030.70 CR

LTQ@LTP

7@1834.80

ATP

1829.97

Var Margin

21.57 %

Circuit Range

1456-2183.8

Delivery %

40.71 %

Value

46.78 CR

ASM/GSM

No

Market Lot

1

Summary

15 May, 2026 | 15:59 को, Onesource Specialty Pharma का शेयर प्राइस आज ₹1834.8 पर है, जो दिन के लिए 14.90% की 0.82 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1777.00 और ₹1860.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1057.00 से ₹2248.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Onesource Specialty Pharma ने 255649 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹114621201 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹182997 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 7,183480 रही। यह स्टॉक ₹1456-2183.8 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹46.78 CR है। दिन के लिए डिलीवरी परसेंटेज 40.71% रही। इसके अतिरिक्त, Onesource Specialty Pharma वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Onesource Specialty Pharma Fundamentals

P/E Ratio

0

P/B Ratio

3.61

Div. Yield

0

Sector P/E

71.32

Sector P/B

3.47

Sec. Div. Yield

0.56

Onesource Specialty Pharma Resistance and Support

Pivot 1809.97

Resistance

First Resistance

1859.84

Second Resistance

1899.77

Third Resistance

1949.64

Support

First Support

1770.04

Second Support

1720.17

Third Support

1680.24

Onesource Specialty Pharma Shareholding Pattern

2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

30.48%

Mutual Fund

10.13%

Insurance

3.35%

Foreign Institutional Investors

17.5%

Domestic Institutional Investors

7.13%

Retail

31.41%

Others

0%

Total Promoters

MAR '26

30.48%

Onesource Specialty Pharma Corporate Actions

Date	Agenda
2026-05-13	Audited Results
2026-01-23	Quarterly Results

Onesource Specialty Pharma News

Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Onesource Specialty Pharma announced strong Q4 FY26 results with revenue growing 47% QoQ to Rs.4,282 million and EBITDA expanding over 5x. The company also reaffirmed its FY28 guidance.

May 13 2026 13:05:00

Onesource Specialty Pharma Ltd - 544292 - Board Meeting Outcome for Intimation Of The Outcome Of The Board Meeting Dated May 13, 2026 For Approval Of The Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2026

Onesource Specialty Pharma board approved FY26 financial results, reporting a cons. net loss of ₹738.03 mn, significantly widening from ₹179.71 mn loss in FY25. Also appointed B S R & Co LLP as new statutory auditors for 5 years, replacing Deloitte Haskins & Sells.

May 13 2026 13:05:00

Onesource Specialty Pharma Ltd - 544292 - Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015

Onesource Specialty Pharma's Board of Directors is scheduled to meet on May 13, 2026. The agenda includes considering and approving the audited financial results for the quarter and year ended March 31, 2026.

May 07 2026 18:05:00

Onesource Specialty Pharma Limited

Onesource Specialty Pharma Ltd. partner Orbicular received Health Canada approval for a generic version of Ozempic® (semaglutide injection). This enables commercialization for the first two generic entrants in Canada's significant semaglutide market, with OneSource supporting manufacturing from its US FDA-approved facility in Bengaluru.

May 04 2026 08:05:00

Onesource Specialty Pharma Limited

Onesource Specialty Pharma Ltd. partner Orbicular received Health Canada approval for a generic version of Ozempic® (semaglutide injection). This enables commercialization for the first two generic entrants in Canada's significant semaglutide market, with OneSource supporting manufacturing from its US FDA-approved facility in Bengaluru.

May 04 2026 08:05:00

Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

OneSource Specialty Pharma's partner, Orbicular, received Health Canada approval for a generic version of Ozempic (semaglutide injection). This enables commercialization in Canada's significant market, with OneSource providing manufacturing from its US FDA-approved facility, strengthening its CDMO presence.

May 04 2026 08:05:00

Onesource Specialty Pharma Limited

OneSource Specialty Pharma Limited's partner, Dr. Reddy's Laboratories, received Health Canada approval for its generic Semaglutide Injection. OneSource will serve as the CDMO partner, handling scale-up and commercial manufacturing from its US-FDA approved facility in Bengaluru. This strengthens their collaboration and validates OneSource's manufacturing capabilities.

Apr 29 2026 09:04:00

Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Onesource's partner, Dr. Reddy's Laboratories, received Health Canada approval for generic Semaglutide Injection. Onesource will serve as the CDMO partner for scale-up and commercial manufacturing from its US-FDA approved facility in Bengaluru.

Apr 29 2026 09:04:00

Onesource Specialty Pharma Limited

OneSource's Sterile Product Division in Bangalore received an EU GMP Certificate from German authorities. This certification confirms compliance with EU GMP requirements for sterile products, ensuring quality for small volume liquids and testing.

Apr 28 2026 21:04:00

Onesource Specialty Pharma shares gain after equity worth ₹408 crore changes hands in block deals

Onesource Specialty Pharma's partner has received USFDA approval for a generic version of Ozempic, a development that is expected to create new contract manufacturing opportunities for Onesource, impacting its contract development and manufacturing organization (CDMO) services positively.

Apr 21 2026 11:04:00

NSE : 29224

BSE : 544292

ISIN : INE013P01021

Onesource Specialty Pharma Management

Name	Position
A Trisha	Company Secretary & Compliance Officer
Arun Kumar	Chairman

Onesource Specialty Pharma Similar Stocks

Acutaas Chemicals Ltd.

2731.00

4.20 (0.15%)

Sai Life Sciences Ltd.

1090.90

-21.60 (1.94%)

Neuland Laboratories Ltd.

16590.00

-90.00 (0.54%)

Pfizer Ltd.

4954.70

273.60 (5.84%)

Natco Pharma Ltd.

1199.10

-5.30 (0.44%)

Astrazeneca Pharma India Ltd.

8468.50

116.50 (1.39%)

Eris Lifesciences Ltd.

1370.90

-3.00 (0.22%)

Granules India Ltd.

736.20

0.90 (0.12%)

Cohance Lifesciences Ltd.

423.20

-22.00 (4.94%)

Poly Medicure Ltd.

1498.90

-22.10 (1.45%)

Onesource Specialty Pharma FAQs

Onesource Specialty Pharma शेयर का खरीद मूल्य 1834.8 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Onesource Specialty Pharma शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Onesource Specialty Pharma शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Onesource Specialty Pharma शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.61 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Onesource Specialty Pharma शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.47 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Onesource Specialty Pharma का मार्केट कैप 21030.70 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Onesource Specialty Pharma शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 2248.00 और 1057.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।